fr 66973 has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsukagoshi, S | 1 |
| Masuda, K; Nakamura, T; Noda, K; Noguchi, H; Shibayama, F; Shimomura, K; Suzuki, A; Takagaki, S | 1 |
| Manda, T; Masuda, K; Matsumoto, S; Mizota, T; Mori, J; Mukumoto, S; Nakamura, T; Nishigaki, F; Oku, T; Shimomura, K | 1 |
3 other study(ies) available for fr 66973 and Leukemia P388
| Article | Year |
|---|---|
[Antitumor candidate compounds under clinical trials in Japan].
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Cisplatin; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Oxazines | 1990 |
A new antitumor antibiotic, FK973: its metabolism in the blood and the antitumor effects of its metabolites on experimental models.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Dealkylation; Dogs; Female; Half-Life; Humans; In Vitro Techniques; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Oxazines | 1989 |
Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Topics: Animals; Antineoplastic Agents; Blood Cells; Bone Marrow; Drug Resistance; Female; Hematopoietic Stem Cells; Humans; Leukemia P388; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Oxazines; Transplantation, Heterologous | 1988 |